• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19

tetano

Editor, Senior Moderator
Cell Rep


. 2021 Sep 20;109798.
doi: 10.1016/j.celrep.2021.109798. Online ahead of print.
Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19


Dong-Min Kim[SUP] 1 [/SUP], Yuri Kim[SUP] 2 [/SUP], Jun-Won Seo[SUP] 1 [/SUP], Jooyeon Lee[SUP] 3 [/SUP], Uni Park[SUP] 4 [/SUP], Na-Young Ha[SUP] 2 [/SUP], Jaemoon Koh[SUP] 5 [/SUP], Hyoree Park[SUP] 4 [/SUP], Jae-Won Lee[SUP] 4 [/SUP], Hyo-Jin Ro[SUP] 4 [/SUP], Na Ra Yun[SUP] 1 [/SUP], Da Young Kim[SUP] 1 [/SUP], Sung Ho Yoon[SUP] 1 [/SUP], Yong Sub Na[SUP] 1 [/SUP], Do Sik Moon[SUP] 1 [/SUP], Sung-Chul Lim[SUP] 6 [/SUP], Choon-Mee Kim[SUP] 7 [/SUP], Kyeongseok Jeon[SUP] 4 [/SUP], Jun-Gu Kang[SUP] 8 [/SUP], Na-Yoon Jang[SUP] 4 [/SUP], Hyeongseok Jeong[SUP] 3 [/SUP], Jungok Kim[SUP] 9 [/SUP], Shinhyea Cheon[SUP] 3 [/SUP], Kyung Mok Sohn[SUP] 3 [/SUP], Jae Youg Moon[SUP] 9 [/SUP], Sungmin Kym[SUP] 9 [/SUP], Seung Ro Han[SUP] 10 [/SUP], Myung-Shin Lee[SUP] 10 [/SUP], Hyun-Je Kim[SUP] 11 [/SUP], Woong-Yang Park[SUP] 12 [/SUP], Ji-Yeob Choi[SUP] 13 [/SUP], Hyun-Woo Shin[SUP] 13 [/SUP], Hye-Young Kim[SUP] 13 [/SUP], Chung-Hyun Cho[SUP] 13 [/SUP], Yoon Kyung Jeon[SUP] 5 [/SUP], Yeon-Sook Kim[SUP] 14 [/SUP], Nam-Hyuk Cho[SUP] 15 [/SUP]



Affiliations
Free PMC article

Abstract

Despite the worldwide effect of the coronavirus disease 2019 (COVID-19) pandemic, the underlying mechanisms of fatal viral pneumonia remain elusive. Here, we show that critical COVID-19 is associated with enhanced eosinophil-mediated inflammation when compared to non-critical cases. In addition, we confirm increased T helper (Th)2-biased adaptive immune responses, accompanying overt complement activation, in the critical group. Moreover, enhanced antibody responses and complement activation are associated with disease pathogenesis as evidenced by formation of immune complexes and membrane attack complexes in airways and vasculature of lung biopsies from six fatal cases, as well as by enhanced hallmark gene set signatures of Fcγ receptor (FcγR) signaling and complement activation in myeloid cells of respiratory specimens from critical COVID-19 patients. These results suggest that SARS-CoV-2 infection may drive specific innate immune responses, including eosinophil-mediated inflammation, and subsequent pulmonary pathogenesis via enhanced Th2-biased immune responses, which might be crucial drivers of critical disease in COVID-19 patients.

Keywords: COVID-19; SARS-CoV-2; complement; eosinophil; immune complex; pneumonia.
 
Back
Top Bottom